Pulse Oximetry Screening at 4 Hours of Age to Detect Critical Congenital Heart Defects

Sendelbach, Dorothy; Jackson, Gregory L.; Lai, Susanna S; Fixler, David E; Stehel, Elizabeth K.; Engle, William D.

doi:10.1542/peds.2008-0781

Cited by 56 publications

(35 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…13 These findings have led to exploration of the possibility that pulse oximetry may be useful in detecting hypoxaemia associated with CHDs in apparently healthy newborns, and a number of studies have been published that have used pulse oximetry as a screen for CHDs in this group. 13,[62][63][64][65][66][67][68][69][70][71] In a systematic review published in 2007, we reviewed the eight published studies available at that time. 72 We highlighted a number of problems when assessing the accuracy of this test as there was a wide variation in methodology, particularly patient selection, timing of saturation measurement, cut-off levels for a positive test result, nature of CHD screened for, rigour of follow-up and type of oximeters used ( Table 2).…”

Section: Pulse Oximetrymentioning

confidence: 99%

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.

Ewer

Furmston²,

Middleton³

et al. 2012

Health Technol Assess

127

117

View full text Add to dashboard Cite

How to obtain copies of this and other HTA programme reports An electronic version of this title, in Adobe Acrobat format, is available for downloading free of charge for personal use from the HTA website (www.hta.ac.uk). A fully searchable DVD is also available (see below).Printed copies of HTA journal series issues cost £20 each (post and packing free in the UK) to both public and private sector purchasers from our despatch agents.Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per issue and for the rest of the world £3 per issue. How to order:-fax (with credit card details) -post (with credit card details or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you to either print out your order or download a blank order form. Contact details are as follows:Synergie UK (HTA Department) Digital House, The Loddon Centre Wade Road Basingstoke Hants RG24 8QW Email: orders@hta.ac.uk Tel: 0845 812 4000 -ask for 'HTA Payment Services' (out-of-hours answer-phone service) Fax: 0845 812 4001 -put 'HTA Order' on the fax header Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to University of Southampton and drawn on a bank with a UK address.Paying by credit card You can order using your credit card by phone, fax or post. SubscriptionsNHS libraries can subscribe free of charge. Public libraries can subscribe at a reduced cost of £100 for each volume (normally comprising 40-50 titles). The commercial subscription rate is £400 per volume (addresses within the UK) and £600 per volume (addresses outside the UK). Please see our website for details. Subscriptions can be purchased only for the current or forthcoming volume.How do I get a copy of HTA on DVD?Please use the form on the HTA website (www.hta.ac.uk/htacd/index.shtml). HTA on DVD is currently free of charge worldwide.The website also provides information about the HTA programme and lists the membership of the various committees. HTAPulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness NIHR Health Technology Assessment programmeThe Health Technology Assessment (HTA) programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'Na...

show abstract

Section: Pulse Oximetrymentioning

confidence: 99%

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.

Ewer

Furmston²,

Middleton³

et al. 2012

Health Technol Assess

127

117

View full text Add to dashboard Cite

show abstract

“…As a result, several investigators evaluated the use of routine pulse oximetry to identify infants with CCHD before discharge from delivery units and reported on its validity. 8,[11][12][13][14][15][16][17] In the United States, many state legislatures have mandated universal pulse oximetry screening of newborns, which was endorsed by the Secretary of Health and Human Services in 2011. The scientific committees of the American Academy of Pediatrics and the American Heart Association recommended that additional studies be conducted in large diverse populations across a broad range of delivery systems to determine whether pulse oximetry screening in neonates improves outcomes in infants with CCHD.…”

mentioning

confidence: 99%

Age at Referral and Mortality From Critical Congenital Heart Disease

Fixler

Nembhard

et al. 2014

Pediatrics

Self Cite

View full text Add to dashboard Cite

BACKGROUND AND OBJECTIVE: Newborn pulse oximetry screening is recommended to promote early referral of neonates with critical congenital heart disease (CCHD) and reduce mortality; however, the impact of late referral on mortality is not well defined. The purpose of this population-based study was to describe the association between timing of referral to a cardiac center and mortality in 2360 liveborn neonates with CCHD. METHODS: Neonates with CCHD born before pulse oximetry screening (1996–2007) were selected from the Texas Birth Defects Registry and linked to state birth and death records. Age at referral was ascertained from date of first cardiac procedure at a cardiac center. Logistic and Cox proportional hazards regression models were used to estimate factors associated with late referral and mortality; the Kaplan-Meier method was used to estimate 3-month survival. RESULTS: Median age at referral was 1 day (25th–75th percentile: 0–6 days). Overall, 27.5% (649 of 2360) were referred after age 4 days and 7.5% (178 of 2360) had no record of referral. Neonatal mortality was 18.1% (277 of 1533) for those referred at 0 to 4 days of age, 9.0% (34 of 379) for those referred at 5 to 27 days of age, and 38.8% (69 of 178) for those with no referral. No improvement in age at referral was found across the 2 eras within 1996–2007. CONCLUSIONS: A significant proportion of neonates with CCHD experienced late or no referral to cardiac specialty centers, accounting for a significant number of the deaths. Future population-based studies are needed to determine the benefit of pulse oximetry screening on mortality and morbidity.

show abstract

“…Yenidoğan bir bebeğin ilk satürasyon ölçümünün kaçıncı saatinde yapılması gerektiği de tartışılmıştır 20,21,[27][28][29] . Satürasyon ölçümün çok geciktirilirse, hastaların klinik bulgu ve semptomları, satürasyon düşüklüğünden daha önce fark edileceğinden, taramanın mantığına ters düşülebileceğivurgulanmıştır [28][29][30] .…”

Section: Pulse Oksimetri Taraması İçin En Uygun Zamanlama Nedir?unclassified

“…Satürasyon ölçümün çok geciktirilirse, hastaların klinik bulgu ve semptomları, satürasyon düşüklüğünden daha önce fark edileceğinden, taramanın mantığına ters düşülebileceğivurgulanmıştır [28][29][30] . Pulse oksimetri taramasındanönce klinik bulgu veren vaka oranı değişik çalışmalarda %50 ile 100 arasında verilmiştir 25,28,30 .…”

Section: Pulse Oksimetri Taraması İçin En Uygun Zamanlama Nedir?unclassified

“…Ayrıca, satürasyon düşüklüğü hangi nedenle(kardiyak, pulmoner, enfeksiyöz)olursa olsun, erken tanı ve tedavi planlamasının dolayısıyla erken taramanın öneminede değinilmiştir 14,26,28 . Dawson ve arkadaşlarının geniş bir seride yaptıkları yenidoğanların ilk dakikalarına ait satürasyon ölçümlerinden oluşan bir çalışmada preduktal satürasyonun %90'ın üzerine ulaşması median 7.9 dakikayı bulmaktadır 19 .…”

Section: Pulse Oksimetri Taraması İçin En Uygun Zamanlama Nedir?unclassified

See 1 more Smart Citation

Yenidoğanda Satürasyon Taraması

Özgür¹,

Ceylan²,

Karademir³

2014

Arşiv Kaynak Tarama Dergisi

View full text Add to dashboard Cite

In terms of the incidence, congenital heart diseases ranks first among congenital problems in the neonatal period. Although some of those diseases are with significant clinical findings, they might be insignificant in most cases. Standardization methods have been studied in variety of points, and oxygen saturation by pulse oximetry is thougt to be a good alternative to physical examination. In several studies, it is mentioned that some of congenital heart diseases are diagnosed by saturation screening. However, the benefits of this method are marred with the false negative and false positive rates. Therefore, in 2011 American Academy of Pediatrics has revised its saturation algorithm for scanning. It was aimed to have a standardization in saturation detecting time and evaluation of achieved saturation in newborns. Despite all efforts, some newborns with congenital heart disease are not diagnosed before discharging. We beleive that the details of saturation measurements are needed to be carefully evaluated because although these measurements are widely used their details are not well known. Key words: Newborn screening,congenital heart defects,cyanosis. ÖZET Doğumsal kalp hastalıkları sıklık açısından yenidoğan döneminde görülen konjenital problemler arasında ilk sırada yer almaktadır. Hastalıklardan bazıları belirgin klinik bulgular verse de; nadir olmayarak bulguların silik olabileceğini görmekteyiz. İnsan gözünün yanılabileceği noktalarda çeşitli standardizasyon yöntemleri araştırılmış; ve pulse oksimetre ile oksijen satürasyonu taranmasının iyi bir alternatif olabileceği üzerinde durulmuştur. Çeşitli çalışmalarda, klinik olarak farkedilemeyen bazı doğumsal kalp hastalıklarına satürasyon taraması ile tanı konulduğundan bahsedilmektedir. Ancak bu yarar yöntemin yalancı negatiflik ve yalancı pozitifliği oranları ile gölgelenmektedir. Bu nedenle

show abstract

Pulse Oximetry Screening at 4 Hours of Age to Detect Critical Congenital Heart Defects

Cited by 56 publications

References 20 publications

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.

Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.

Age at Referral and Mortality From Critical Congenital Heart Disease

Yenidoğanda Satürasyon Taraması

Contact Info

Product

Resources

About